Fineheart preview
Fineheart favicon

Fineheart Review

April 2026

$16M
Revenue
100
Employees
35%
Growth
Estimated Revenue
$16M
Total Employees
100
Employee Growth
35%
Industry
Biotech
Location
Pessac
About

Our mission is to address the unmet need of patients with sever heart failure

Global Rank
N/A

What is Fineheart's Revenue?

Fineheart's estimated revenue is $16M.

What does Fineheart do?

Our mission is to address the unmet need of patients with sever heart failure

CompanyRevenueEmployeesGrowthFunding
Dermavant SciencesDermavant Sciences
$99.4M45839.9%N/A
Metrum Research GroupMetrum Research Group
$20.6M13322.5%N/A
Clovis OncologyClovis Oncology
$156.1M146-69.8%$145M
ArcherDXArcherDX
$3.5M45-24.5%$150M
InscriptaInscripta
$1.6M210.0%$459.5M
CerapedicsCerapedics
$67.3M31015.4%$180.7M
Stone Clinical LaboratoriesStone Clinical Laboratories
$8.5M55-2.2%N/A
Apellis PharmaceuticalsApellis Pharmaceuticals
$256.3M1,0258.9%$168.5M
CreoSalusCreoSalus
$2.8M18-31.8%N/A
MSBiotecMSBiotec
$9.1M59-9.4%N/A
📝CMS1
🎯CSS Frameworks2
🔧Customer Support1
💳E-commerce & Payments1
🎨JavaScript Libraries3
🔧Maps1
Performance1
🔧Programming Languages1
🔧Web Standards2
Tracking & Analytics4
G
Google Analytics
C
Cloudflare
G
Google APIs
G
Google Static

Technology detection powered by advanced web analysis

Powered byTechlist.ai